EU Authorizes Use of Adapted Vaccine for COVID-19 Variant

The European Commission has authorized an updated COVID-19 vaccine from Pfizer/BioNtech to be used in EU countries' vaccination campaigns this autumn to target the dominant Omicron XBB.1.5 variant.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/996052?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost